APA (7th ed.) Citation

C, A., J, A., K, G., B, C., C, T., L, N., . . . T, P. (2025). Comparison of standard versus adjusted dose of enoxaparin for venous thromboembolism prophylaxis in patients with obesity and cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 10781552251345413. https://doi.org/10.1177/10781552251345413

Chicago Style (17th ed.) Citation

C, Angerman, et al. "Comparison of Standard Versus Adjusted Dose of Enoxaparin for Venous Thromboembolism Prophylaxis in Patients with Obesity and Cancer." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 2025: 10781552251345413. https://doi.org/10.1177/10781552251345413.

MLA (9th ed.) Citation

C, Angerman, et al. "Comparison of Standard Versus Adjusted Dose of Enoxaparin for Venous Thromboembolism Prophylaxis in Patients with Obesity and Cancer." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 2025, p. 10781552251345413, https://doi.org/10.1177/10781552251345413.